Abstract
In this article, we report the case of a woman in whom was found an abdominal mass during pregnancy and who underwent nephrectomy and extraction of the emboli after delivery. The kidney had a volume of 15 × 10 × 8 cm and pathological diagnosis was primary Ewing's sarcoma. The patient was treated with conventional chemotherapy for 1 year after surgery, at which time multiple metastases were found. From this case, we surmise that hormonal changes that occur during pregnancy may accelerate the growth of Ewing's sarcoma of the kidney, suggesting that renal tumors in pregnant women demand serious attention and that anti-cancer treatment should begin as soon as possible.
References
1.
Abudu A, Mangham DC, Reynolds GM, et al: Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis. Br J Cancer 1999;79:1185-1189.
2.
Venkitaraman R, George MK, Ramanan SG, et al: A single institution experience of combined modality management of extra skeletal Ewings sarcoma. World J Surg Oncol 2007;5:3.
3.
Ozkanli SS, Yildirim A, Zemheri E, Gucer Fİ, Aydin A, Caskurlu T: Primary synovial sarcoma of the kidney. Urol Int 2014;92:369-372.
4.
Rodriguez-Galindo C, Marina NM, Fletcher BD, et al: Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer 1997;79:2243-2250.
5.
Ozkanli SS, Yildirim A, Zemheri E, Gucer Fİ, Aydin A, Caskurlu T: A case of renal cell carcinoma with inferior vena cava tumor thrombus diagnosed during pregnancy. Urol Int 2014;92:122-124.
6.
Berczi C, Flasko T: Renal tumor in pregnancy: a case report and review of the literature. Urol Int 2015, Epub ahead of print.
7.
Alonso AH, Gárate MM, Amo FH, et al: Primary renal Ewing's sarcoma. Arch Esp Urol 2011;64:636-639.
8.
Zucman J, Delattre O, Desmaze C, et al: Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer 1992;5:271-277.
9.
de Alava E, Gerald WL: Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000;18:204-213.
10.
Jerry DJ, Dunphy KA, Hagen MJ: Estrogens, regulation of p53 and breast cancer risk: a balancing act. Cell Mol Life Sci 2010;67:1017-1023.
11.
Lessnick SL, Dacwag CS, Golub TR: The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 2002;1:393-401.
12.
Mathelin C, Annane K, Dufour P, Liegeois P, Bergerat JP: Chemotherapy for breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;123:260-262.
13.
Bond GL, Hu W, Levine AJ: MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets 2005;5:3-8.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.